Maryland biotechs better positioned after strong 2006

01/2/2007 | Washington Times, The

Maryland's biotech companies made significant progress last year in their march to market commercial products, analysts say. More companies turned the corner "in terms of receiving significant money and the realization of new drugs coming to market," said Bob Eaton, president of MdBio Foundation.

View Full Article in:

Washington Times, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
White Plains, NY
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ